Evidence map›Paper›PMID 26460022›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.

Adán de Salas-Quiroga, Javier Díaz-Alonso, Daniel García-Rincón, Floortje Remmers, David Vega, María Gómez-Cañas, Beat Lutz, Manuel Guzmán, Ismael Galve-Roperh

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04422600 (Fetal Exposure to Cannabinoids), which is not on this map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04422600 completednot on this mapstarted 2020, after this paper: background citation

Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

Typeobservational_patient_registrySponsorUniversity of ArkansasRan2020 to 2023Enrolled72ConditionsFetal Exposure Timing UnspecifiedArmsThere is no other intervention, only clinical treatment.
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Evidence on the effect of in-utero cannabis exposure in neonates.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Review
  8. Prenatal Downregulation of CBThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Transgenerational effects of perinatal cannabis exposure on female reproductive parameters in mice.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Cannabis exposure during pregnancy and perinatal outcomes: A cohort study.Acta obstetricia et gynecologica Scandinavica · 2024
    Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Adán de Salas-QuirogaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain;
Javier Díaz-AlonsoCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain;
Daniel García-RincónCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain;
Floortje RemmersInstitute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany;
David VegaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain;
María Gómez-CañasCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology III, Complutense University, 28040 Madrid, Spain.
Beat LutzInstitute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55128 Mainz, Germany;
Manuel GuzmánCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain;
Ismael Galve-RoperhCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28049 Madrid, Spain; Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), 28034 Madrid, Spain; Department of Biochemistry and Molecular Biology I, Complutense University, 28040 Madrid, Spain; igr@quim.ucm.es.ORCID http://orcid.org/0000-0003-3501-2434
Universidad Complutense de Madrid · ESJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CB1 cannabinoid receptor, the main target of Δ(9)-tetrahydrocannabinol (THC), the most prominent psychoactive compound of marijuana, plays a crucial regulatory role in brain development as evidenced by the neurodevelopmental consequences of its manipulation in animal models. Likewise, recreational cannabis use during pregnancy affects brain structure and function of the progeny. However, the precise neurobiological substrates underlying the consequences of prenatal THC exposure remain unknown. As CB1 signaling is known to modulate long-range corticofugal connectivity, we analyzed the impact of THC exposure on cortical projection neuron development. THC administration to pregnant mice in a restricted time window interfered with subcerebral projection neuron generation, thereby altering corticospinal connectivity, and produced long-lasting alterations in the fine motor performance of the adult offspring. Consequences of THC exposure were reminiscent of those elicited by CB1 receptor genetic ablation, and CB1-null mice were resistant to THC-induced alterations. The identity of embryonic THC neuronal targets was determined by a Cre-mediated, lineage-specific, CB1 expression-rescue strategy in a CB1-null background. Early and selective CB1 reexpression in dorsal telencephalic glutamatergic neurons but not forebrain GABAergic neurons rescued the deficits in corticospinal motor neuron development of CB1-null mice and restored susceptibility to THC-induced motor alterations. In addition, THC administration induced an increase in seizure susceptibility that was mediated by its interference with CB1-dependent regulation of both glutamatergic and GABAergic neuron development. These findings demonstrate that prenatal exposure to THC has long-lasting deleterious consequences in the adult offspring solely mediated by its ability to disrupt the neurodevelopmental role of CB1 signaling.

Indexed as

Maternal ExposureAnimalsCerebral CortexDronabinolFemaleMiceNeuronsPregnancyReceptor, Cannabinoid, CB1DronabinolReceptor, Cannabinoid, CB1cannabisCB1 cannabinoid receptorcorticospinalneurodevelopmentseizures

Identifiers

PMID26460022
PMCPMC4640742
OpenAlexW1934223132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.